HIVE Blockchain Technologies (HIVE) had the highest return in 2017 by a US stock with a market cap of $300M to $2B or a market cap of $10B+, returning 3,413.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
HIVE Blockchain Technologies (HIVE) | 2017 | 3,413.74% |
Gravity (GRVY) | 2017 | 801.72% |
XOMA (XOMA) | 2017 | 747.62% |
Cronos (CRON) | 2017 | 592.83% |
Quantum Computing (QUBT) | 2017 | 566.67% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Semler Scientific (SMLR) | 2017 | 429.8% |
Sangamo Therapeutics (SGMO) | 2017 | 429.03% |
Esperion Therapeutics (ESPR) | 2017 | 414.38% |
Dynavax Technologies (DVAX) | 2017 | 367.5% |
EXACT Sciences (EXAS) | 2017 | 286.04% |
Global Industrial (GIC) | 2017 | 281.26% |
BioLife Solutions (BLFS) | 2017 | 270.37% |
Pulse Biosciences (PLSE) | 2017 | 263.08% |
argenx NV ADR (ARGX) | 2017 | 252.74% |
Everi (EVRI) | 2017 | 249.07% |
Uniqure (QURE) | 2017 | 247.34% |
Canopy Growth (CGC) | 2017 | 243.77% |
Alnylam Pharmaceuticals (ALNY) | 2017 | 233.03% |
Lendingtree (TREE) | 2017 | 230.86% |
Roku (ROKU) | 2017 | 228.14% |
P10 (PX) | 2017 | 225.97% |
Astrana Health (ASTH) | 2017 | 220% |
Sage Therapeutic (SAGE) | 2017 | 216.93% |
Axogen (AXGN) | 2017 | 210.99% |
